MLTX — MOONLAKE IMMUNOTHERAPEUTICS COM ISIN#KY61559X1045

Ownership history in TD PRIVATE CLIENT WEALTH LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which TD PRIVATE CLIENT WEALTH LLC reported a position in MOONLAKE IMMUNOTHERAPEUTICS COM ISIN#KY61559X1045 (MLTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 17 +8 +88.9% 0.00% $122 $7.17
2025 Q1 INITIATED 9 — — 0.00% $352 $39.07
% of Fund (quarterly)    MLTX price (monthly, adj. close)

Other funds also holding MLTX

As of 2025 Q4 — sorted by position size

BVF INC/IL 3Y 7Y 8.76% Lion Point Capital, LP 3Y 7Y 4.6% Cormorant Asset Management, LP 3Y 7Y 2.65% Logos Global Management LP 3Y 1.39% Deep Track Capital, LP 3Y 1.08% Vivo Capital, LLC 3Y 7Y 0.85% STEMPOINT CAPITAL LP 0.79% Eagle Health Investments LP 3Y 0.54% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 0.53% Rhenman & Partners Asset Management AB 3Y 7Y 0.45%
← Back to TD PRIVATE CLIENT WEALTH LLC Holdings